We are almost there ...
Dr Reddy’s hit by a big recall in the US
The FDA flags manufacturing issues in multiple strengths of Cinacalcet tablets produced by the pharma major in India.
03 November, 2024•1 min
0
03 November, 2024•1 min
0
Subscribe to read this story
We publish over 500 original, detailed stories every year on startups, corporates, stock markets and economic current affairs.
Limited time offer $125 $99 for 1 year
SUBSCRIBE
Already have an account? Sign In
More in Business
Business
Blaming FII selloff for the market fall is lazy, says Shankar Sharma
The veteran investor goes over the recent stock market crash with a fine-tooth comb, analysing whether the market has bottomed out or a bear run is around the corner.
You may also like
Business
Will changes to the H-1B visa programme adversely impact Indian IT firms?
Contrary to popular perception, any tinkering with the H-1B visa process may not hit local companies hard and may actually end up driving more jobs to India.
Internet
With US nod, UAE scores a big win for advanced AI chips
By green-lighting the export of advanced AI chips to a Microsoft-run facility in the UAE, the US has scored a massive advantage in its tech race against China.
Internet
Why is Swiggy catching flak for its latest quick-delivery promise?
The food and grocery delivery company’s idea of providing prescription drugs in 10 minutes is facing resistance from traditional pharma players.